Description
Our core technology was developed by leading researchers at the University of Washington, a global hub for biomedical innovation. This novel diagnostic system enables the collection of stomach lining cells without sedation or full endoscopy. Designed for use in GI clinics and population screening programs, the few minute procedure supports cytological and molecular analysis for early detection of precancerous and cancerous changes. With an accessible cost target per test, Vericella™ is creating a platform built for scale—not scarcity.
Team Members
Aadil Diwan
Founder